Elevated systolic BP is linked to adverse outcomes in elderly patients.
Treatment with angiotensin-converting enzyme inhibitors was most strongly associated with hyperkalemia.
Treatment linked to improved long-term survival, regardless of underlying kidney function.
The addition of aliskiren to enalapril led to more adverse events in patients with chronic heart failure without an increase in benefit.
More than half of high-risk atrial fibrillation patients are not prescribed oral anticoagulants.
Trajectory data indicate that childhood BP levels correlate with BP status at age 38 years.
Patients with PsAFonset are part of a distinct demographic and often have poorer clinical outcomes.
No increased in hospitalization rate was found in patients on incretin-based drugs with heart failure.
In addition to tai chi, traditional Chinese exercises have been found to improve quality of life for patients with cardiovascular disease.
Researchers found a correlation between low discharge osmolality and elevated all-cause mortality in heart failure patients.
Genotype was not predictive of onset or severity of atrial fibrillation.
Measurements were off 4 out of 5 times when popular mobile application was tested.
In these patients, systolic blood pressure at night was elevated by an average of 2.9 mm Hg.
Effect seen in women, not men; strongest effect seen in the highest tertile of DASH scores.
Avoiding salt and weight gain, among other triggers, can help lower elevated blood pressure.
A new large scale study found that depending on baseline systolic blood pressure (SBP) level, the use of antihypertensive medication led to different outcomes in patients with diabetes.
Small absolute benefit seen in SPRINT must be balanced with increased adverse event rates.
Greater visit-to-visit variability in systolic blood pressure is associated with a higher risk of ESRD or a 50% or greater decrease in eGFR.
Masked HTN common among patients with chronic kidney disease; also linked to low eGFR, proteinuria.
Team says the treatment threshold is too high for those over 60 years of age.
After adjustment for multiple variables, PP linked to all outcomes except stroke, cardiovascular death.
Changes in individual lifestyles and how foods are produced are needed to lower consumption.
Research challenges previous findings that suggest ACE inhibitors have greater benefits.
Decrease in age-adjusted death rates from 2000 to 2012; increase from 2012 to 2014.
Online communications reduced need for phone calls and office visits for many.
Renal denervation appears relatively safe and effective, according to recent research.
Sodium restriction linked to increased risk of death or heart failure hospitalization.
Reductions in risks of major CVD events, coronary heart disease, stroke, and heart failure.
Drug found to limit worsening of the disease and reduce the need for hospitalization.
Nitrates reduce activity, quality of life, researchers find.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)